Table 1 Artemisin-containing oral pharmaceutical products obtained from registered pharmacies in Dar-es-Salaam, Tanzania, 2005
Product/active ingredient(s) | Formulation | Country of origin* | 2005 availability (n = 29) | Named in the top 3 sellers in 2005 (n = 28) | Mean selling price 2005†|
|---|---|---|---|---|---|
1. artemether/lumefantrine | 20/120 mg tablets, co-formulated | Switzerland | 21 (72.4%) | 5 (17.9%) | $ 7.59 |
2. artesunate and mefloquine | 200 mg and 250 mg tablets, co-packaged | Switzerland | 17 (58.6%) | 0 | $ 7.05 |
3. artesunate | 50 mg tablets | China | 6 (20.7%) | 0 | $ 4.62 |
4. artesunate | 50 mg tablets | France | 24 (82.8%) | 7 (25.0%) | $ 5.48 |
5. artesunate | 50 mg tablets | Switzerland | 8 (27.6%) | 0 | $ 5.26 |
6. artesunate | 50 mg tablets | Belgium | 28 (96.6%) | 3 (10.7%) | $ 3.53 |
7. artesunate | 50 mg tablets | India | 17 (58.6%) | 0 | $ 2.51 |
8. artesunate | 100 mg tablets | Belgium | 28 (96.6%) | 28 (100%) | $ 4.99 |
9. artesunate | 100 mg tablets | Tanzania | 7 (24.1%) | 1 (3.6%) | $ 2.19 |
10. artesunate | 100 mg tablets | Tanzania | 20 (69.0%) | 6 (21.4%) | $ 1.92 |
11. artesunate | 100 mg tablets | Kenya | 2 (6.9%) | 0 | $ 2.31 |
12. artesunate | 200 mg tablets | Switzerland | 19 (65.5%) | 1 (3.6%) | $ 6.72 |
13. artemether | 40 mg tablets | India | 8 (27.6% 0 | 0 | $ 2.24 |
14. artemether | 50 mg tablets | China | 24 (82.8%) | 15 (53.6%) | $ 4.74 |
15. artemether | 180 mg/60 ml suspension | Belgium | 18 (62.1%) | 0 | $ 4.65 |
16. artemether | 300 mg/100 ml suspension | Belgium | 3 (10.3%) | 0 | $ 5.75 |
17. dihydroartemisinin | 60 mg tablets | Korea | 18 (62.1%) | 0 | $ 4.36 |
18. dihydroartemisinin | 60 mg tablets | China | 25 (86.2%) | 9 (35.7%) | $ 4.55 |
19. dihydroartemisinin | 160 mg/80 ml suspension | China | 20 (69.0%) | 0 | $ 4.18 |